Independent valuation of PsyLabs values Psyence Biomed’s stake at approximately $2 million, doubling in value. Debt-for-equity swap with Psyence Group and Newcourt SPAC Sponsor ...
The biggest contributor to the company’s growth was sales of new custom AI acceleration chips for Amazon.com and other builders of hyperscale data centers.
Revenue generated from pharma research and development services was RMB24.9 million (US$3.5 million) for the three months ended September 30, 2024, representing a 27.1% increase from RMB19.6 million ...